• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌。保乳治疗的成功:两项单机构非随机前瞻性研究的共同经验。

Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.

作者信息

Lagios M D, Silverstein M J

机构信息

Breast Cancer Consultation Service, St. Mary's Medical Center, San Francisco, USA.

出版信息

Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.

PMID:9115503
Abstract

A combined database of 342 patients with DCIS treated by lumpectomy alone versus lumpectomy and radiation therapy with a median 82-month follow-up is summarized in this joint study. Reproducible subtype classification and common methods of mammographic-pathologic correlation and complete tissue processing are unique features of this database, and they permit outcome to be analyzed by pathologic subtype, size, and margine status. Striking differences are noted in local control rates analyzed by subtype, which were largely independent of irradiation (see Table 1). Analysis of local recurrence-free survival restricted to those cases with a 10 mm or larger free margin width revealed no significant differences between the irradiated and nonirradiated groups. The local recurrence rates were 5% in those treated by lumpectomy alone and 4.5% in those treated by lumpectomy and irradiation (Table 4). Although differences in local recurrence rates for DCIS with a 10 mm plus free margin, with or without irradiation, were noted, they were not large. For DCIS patients with adequate (10 mm or more) or intermediate (1-9 mm) margin width, there was a reduction in local recurrence limited to the high-grade subtype (group III) with radiation therapy; an absolute 8% reduction for those with adequate margins and 11% for those with intermediate margins, but the difference was significant only for the latter group (Table 5). However, no significant differences were noted for the lower grade DCIS subtypes (groups I and II). For DCIS patients with inadequate margins (i.e., less than 1 mm), irradiation provided no benefit for local control. We conclude that an adequate surgical excision for DCIS, defined as a free margin of 10 mm or more, largely makes moot the question of local control related to pathologic subtype and treatment modality. Specifically, adequately excised high-grade (group III) DCIS received a benefit for local control from radiation therapy of only 8% within the median follow-up period. This difference is not significant. The impact of DCIS size or extent on local recurrence is much smaller than margin width (see Table 3). Significant differences achieved by radiation therapy were demonstrable only for the smallest size group (15 mm or less) in the highgrade subtype (group III). Differences in local recurrence rates for low and intermediate subtypes (group I and II) based on radiation therapy could not be demonstrated within the three size categories used in the study. We conclude that although adequate margins are more difficult to achieve for larger or more extensive DCIS, size alone is not a prohibition to breast conservation.

摘要

这项联合研究总结了一个包含342例仅接受肿块切除术与接受肿块切除术加放射治疗的导管原位癌(DCIS)患者的综合数据库,中位随访时间为82个月。可重复的亚型分类、乳腺X线摄影-病理相关性的常用方法以及完整的组织处理是该数据库的独特特征,它们使得能够按病理亚型、大小和切缘状态分析结果。按亚型分析的局部控制率存在显著差异,这些差异在很大程度上与放疗无关(见表1)。对切缘宽度为10毫米或更大的病例的局部无复发生存率分析显示,放疗组与未放疗组之间无显著差异。仅接受肿块切除术的患者局部复发率为5%,接受肿块切除术加放疗的患者局部复发率为4.5%(表4)。虽然注意到切缘宽度为10毫米及以上的DCIS无论是否接受放疗,其局部复发率存在差异,但差异不大。对于切缘宽度足够(10毫米或更多)或中等(1 - 9毫米)的DCIS患者,放疗仅使高级别亚型(III组)的局部复发有所减少;切缘足够的患者绝对降低了8%,切缘中等的患者绝对降低了11%,但仅后一组差异有统计学意义(表5)。然而,低级别DCIS亚型(I组和II组)未观察到显著差异。对于切缘不足(即小于1毫米)的DCIS患者,放疗对局部控制无益处。我们得出结论,对于DCIS,定义为切缘宽度10毫米或更多的充分手术切除在很大程度上使与病理亚型和治疗方式相关的局部控制问题变得没有实际意义。具体而言,在中位随访期内,充分切除的高级别(III组)DCIS从放疗中获得的局部控制益处仅为8%。这种差异无统计学意义。DCIS大小或范围对局部复发的影响远小于切缘宽度(见表3)。放疗仅在高级别亚型(III组)中最小尺寸组(15毫米或更小)显示出显著差异。在该研究使用的三个大小类别中,未显示低级别和中级别亚型(I组和II组)基于放疗的局部复发率差异。我们得出结论,虽然对于更大或范围更广的DCIS更难获得足够的切缘,但仅大小本身并非保乳的禁忌证。

相似文献

1
Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.导管原位癌。保乳治疗的成功:两项单机构非随机前瞻性研究的共同经验。
Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.
2
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
3
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.导管原位癌治疗后局部复发的预测因素:一项荟萃分析。
Cancer. 1999 Feb 1;85(3):616-28.
4
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.保乳治疗的导管原位癌患者切缘阴性的界定:芝加哥大学的经验
Breast J. 2005 Jul-Aug;11(4):242-7. doi: 10.1111/j.1075-122X.2005.21617.x.
5
Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.微浸润性乳腺癌:单机构经验的临床病理分析
Cancer. 2000 Mar 15;88(6):1403-9.
6
Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease.乳腺导管原位癌:病理及乳腺X线特征与疾病范围的相关性
Am Surg. 1997 Dec;63(12):1079-83.
7
Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.乳腺导管原位癌保乳及放疗后切缘状态对局部复发的影响。
J Clin Oncol. 2009 Apr 1;27(10):1615-20. doi: 10.1200/JCO.2008.17.5182. Epub 2009 Mar 2.
8
The influence of margin width on local control of ductal carcinoma in situ of the breast.切缘宽度对乳腺导管原位癌局部控制的影响。
N Engl J Med. 1999 May 13;340(19):1455-61. doi: 10.1056/NEJM199905133401902.
9
An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.一项独立验证Van Nuys原位导管癌预后指数效用的尝试。
Cancer. 2007 Dec 15;110(12):2648-53. doi: 10.1002/cncr.23089.
10
Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.MammoSite球囊近距离放射治疗纯导管原位癌局部乳腺照射的初步结果与评估:一项II期临床研究。
Am J Surg. 2006 Oct;192(4):427-33. doi: 10.1016/j.amjsurg.2006.06.013.

引用本文的文献

1
Polygon method: A systematic margin assessment for breast conservation.多边形法:保乳治疗的系统边缘评估。
Cancer Med. 2019 Jul;8(7):3359-3369. doi: 10.1002/cam4.2211. Epub 2019 May 7.
2
Evaluation of intraductal delivery of poly(ethylene glycol)-doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)-like lesions in rats.聚乙二醇-阿霉素共轭纳米载体导管内给药治疗大鼠原位导管癌(DCIS)样病变的评估。
J Interdiscip Nanomed. 2018 Oct 15;3(3):146-159. doi: 10.1002/jin2.51. eCollection 2018 Sep.
3
Ductal carcinoma in situ: recent advances and future prospects.
导管原位癌:最新进展与未来展望
Int J Surg Oncol. 2012;2012:347385. doi: 10.1155/2012/347385. Epub 2012 May 17.
4
Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review.导管原位癌降期和升期的研究范式:手术治疗综述
Int J Surg Oncol. 2012;2012:560493. doi: 10.1155/2012/560493. Epub 2012 May 16.
5
Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?动态对比增强磁共振成像中纯导管原位癌的特征:非高级别和高级别是否表现出不同的影像学特征?
J Oncol. 2010;2010. doi: 10.1155/2010/431341. Epub 2010 Sep 21.
6
A review of current practices in breast conservation surgery in the UK.英国保乳手术当前实践的综述。
Ann R Coll Surg Engl. 2007 Mar;89(2):118-23. doi: 10.1308/003588407X155473.
7
The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions.乳腺浸润前疾病的诊断与管理:与浸润前病变管理相关的问题。
Breast Cancer Res. 2003;5(6):309-12. doi: 10.1186/bcr649. Epub 2003 Oct 9.